Fundamentals Overview
MSCI Inc. is in the middle of its 52-week range with premium valuation, trending upward today.
Valuation premium
Intrinsic value (DCF)
-40.2% downside vs price
Profitability
Risk (Beta)
1.29 — higher vol
Earnings & growth
BullzEye Analysis
Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
Sentiment improving (3 upgrades)
Pressures (Sell):
DCF 40.2% downside vs price · 3M vs S&P 500: -5.2%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 4, Equal Weight: 8, Outperform: 6, Overweight: 11, Strong Buy: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $335.11; current price is $560.07. That’s a -40.2% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 36 |
| DCF value (model) | $335.11 (-40.2% vs price) |
| PEG (TTM) | 4.29 |
| P/B (TTM) | N/A |
| P/S (TTM) | 13.13 |
| P/FCF (TTM) | 26.56 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 0.9 |
| Quick Ratio (TTM) | 0.9 |
| Cash Ratio (TTM) | 0.28 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 38.36% |
| Gross margin (TTM) | 82.44% |
| Operating margin (TTM) | 54.67% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for MSCI.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-04-01 |
| Raymond James | upgrade | Outperform | Strong Buy | 2026-03-17 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-01-29 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2026-01-29 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-01-14 |
| Barclays | maintain | Overweight | Overweight | 2025-10-29 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-10-29 |
| JP Morgan | maintain | Overweight | Overweight | 2025-10-29 |
| UBS | maintain | Buy | Buy | 2025-10-29 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-10-14 |
| JP Morgan | maintain | Overweight | Overweight | 2025-09-10 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-07-23 |
| JP Morgan | maintain | Overweight | Overweight | 2025-07-21 |
| UBS | maintain | Buy | Buy | 2025-07-08 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-07-08 |
| Evercore ISI Group | maintain | Outperform | Outperform | 2025-04-23 |
| RBC Capital | maintain | Outperform | Outperform | 2025-04-16 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-04-16 |
| JP Morgan | maintain | Overweight | Overweight | 2025-04-16 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-04-09 |
| Barclays | maintain | Overweight | Overweight | 2025-04-04 |
| JP Morgan | maintain | Overweight | Overweight | 2025-01-30 |
| RBC Capital | maintain | Outperform | Outperform | 2025-01-30 |
| Barclays | maintain | Overweight | Overweight | 2025-01-30 |
| JP Morgan | maintain | Overweight | Overweight | 2025-01-21 |
| Goldman Sachs | upgrade | Neutral | Buy | 2024-12-18 |
| Morgan Stanley | maintain | Overweight | Overweight | 2024-12-12 |
| Wolfe Research | upgrade | Peer Perform | Outperform | 2024-12-12 |
| Morgan Stanley | maintain | Overweight | Overweight | 2024-10-30 |
| UBS | maintain | Buy | Buy | 2024-10-30 |